INMARSAT
23.5.2022 10:02:11 CEST | Business Wire | Press release
Inmarsat and Honeywell are setting a new benchmark in satellite communications with the launch of SwiftJet , their latest inflight connectivity service for the business aviation industry. It will enter commercial service in the first half of 2023 and deliver the fastest ever speeds over L-band.
As one of the first new services to be introduced on Inmarsat’s ELERA satellite network , SwiftJet will offer seamless global coverage across flight routes with maximum speeds of 2.6Mbps, up to six times faster than Inmarsat’s existing business aviation connectivity solution over L-band. This will allow passengers to create a secure ‘office in the sky’ with enhanced capabilities for video calls, web browsing, email, texting, cloud-syncing and collaboration tools such as Microsoft Teams. Social media and video applications such as TikTok and YouTube, which were previously challenging over L-band, will also be enabled.
As the latest addition to Inmarsat’s market-leading portfolio of business aviation inflight connectivity services, SwiftJet will be available alongside Jet ConneX (JX) and SwiftBroadband (SBB), which have been activated on thousands of jets worldwide. JX is the most popular and widely-adopted premium, high-speed solution available today, powered by a global constellation of Ka-band satellites . Additionally, SBB offers speeds of 432Kbps over L-band using smaller antennas that are suitable as a secondary system to JX or as primary connectivity for smaller or older aircraft.
SwiftJet uses advanced hardware from Inmarsat’s partner Honeywell, which can be equipped on a broad range of aircraft and also supports cockpit and safety services. Existing customers of Inmarsat’s SBB service will benefit from a natural upgrade path without needing to replace any externally-mounted aircraft equipment, while new customers will experience the same ease of installation as with any Inmarsat L-band terminal. The service also creates new opportunities in the smaller jet market, which have previously been restricted to basic voice or text connectivity that fails to meet the needs of modern day travellers. It is available to pre-order through Honeywell , with additional incentives in an early adopter campaign.
Inmarsat is launching the ground-breaking service at a critical time for the business aviation industry. Following a period of turbulence over the past two years due to the global pandemic, a recent survey by Inmarsat and Corporate Jet Investor (CJI) found that almost 80% of respondents around the world believe more frequent business aviation flights will be taken in the next year. Furthermore, a staggering 90% feel that online activities will dominate the principals’ time in the air, split between business and leisure.
Kai Tang, Inmarsat’s Head of Business Aviation, said: “Inmarsat prides itself on delivering services that meet the unique and fast-evolving requirements of our customers. As the market leader in business aviation connectivity, Inmarsat developed SwiftJet in response to customer and partner feedback for a faster, more advanced L-band offering. They essentially asked us to amplify L-band capabilities without losing its trademark characteristics of resilience, reliability and availability.
“I am proud to say that SwiftJet delivers all of this and more, unlocking exciting new capabilities in the aircraft cabin and allowing users to connect more devices, and enjoy faster connectivity speeds, whenever and wherever they fly. It comes at a time when business aviation travel is not only returning to pre-pandemic levels, but also experiencing unprecedented demand for inflight connectivity.”
Adam Sheppard, Honeywell Aerospace’s Director of Aircraft Connectivity, said: “SwiftJet represents the latest leap forward for inflight connectivity, combining Inmarsat’s commercial satellite capabilities and Honeywell’s connected aircraft expertise to provide scalable, high-speed satellite communications to passengers at 40,000 feet. With Inmarsat we have created a straightforward upgrade path for SwiftBroadband customers, giving them easy access to unprecedented internet speeds over L-band without having to change wiring or antenna hardware.”
Inmarsat’s ELERA global satellite network delivers the world’s most reliable and flexible global connectivity, with full redundancy and unique resilience in all conditions. ELERA capabilities are being further enhanced with the addition of two Inmarsat-6 satellites , the largest and most sophisticated commercial communications satellites ever built, both of which are scheduled to enter service next year and will support SwiftJet through the 2030s, reinforcing the service’s long-term value. The L-band capacity on each I-6 satellite will be substantially greater than Inmarsat’s 4th generation spacecraft, delivering 50% more capacity per beam in addition to unlimited beam routing flexibility.
The I-6 series of satellites will also play a crucial role in the ongoing growth of Inmarsat’s unique ORCHESTRA dynamic mesh network, which will bring existing geosynchronous (GEO) satellites together with low earth orbit satellites (LEO) and terrestrial 5G to form an integrated, high-performance solution, unmatched by any existing or planned competitor offering.
ENDS
ABOUT INMARSAT
Inmarsat is the world leader in global, mobile satellite communications. It owns and operates the world’s most diverse global portfolio of mobile telecommunications satellite networks, and holds a multi-layered, global spectrum portfolio, covering L-band, Ka-band and S-band, enabling unparalleled breadth and diversity in the solutions it provides. Inmarsat’s long-established global distribution network includes not only the world’s leading channel partners but also its own strong direct retail capabilities, enabling end to end customer service assurance.
The company has an unrivalled track record of operating the world’s most reliable global mobile satellite telecommunications networks, sustaining business and mission critical safety & operational applications for more than 40 years. It is also a major driving force behind technological innovation in mobile satellite communications, sustaining its leadership through a substantial investment and a powerful network of technology and manufacturing partners.
Inmarsat operates across a diversified portfolio of sectors with the financial resources to fund its business strategy and holds leading positions in the Maritime, Government, Aviation and Enterprise satcoms markets, operating consistently as a trusted, responsive and high-quality partner to its customers across the globe.
For further information, follow us: Twitter | LinkedIn | Facebook | YouTube | Instagram .
ABOUT HONEYWELL
Honeywell Aerospace products and services are found on virtually every commercial, defense and space aircraft The Aerospace business unit builds aircraft engines, cockpit and cabin electronics, wireless connectivity systems, mechanical components and more. Its hardware and software solutions create more fuel-efficient aircraft, more direct and on-time flights and safer skies and airports. For more information, visit www.honeywell.com or follow us at @Honeywell_Aero
Honeywell (www.honeywell.com ) is a Fortune 100 technology company that delivers industry-specific solutions that include aerospace products and services; control technologies for buildings and industry; and performance materials globally. Our technologies help aircraft, buildings, manufacturing plants, supply chains, and workers become more connected to make our world smarter, safer, and more sustainable. For more news and information on Honeywell, please visit www.honeywell.com/newsroom
View source version on businesswire.com: https://www.businesswire.com/news/home/20220523005084/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release
Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
